Detalhe da pesquisa
1.
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.
Lancet
; 398(10294): 27-40, 2021 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34102137
2.
Brazil-TNT: A Randomized Phase 2 Trial of Neoadjuvant Chemoradiation Followed by FOLFIRINOX Versus Chemoradiation for Stage II/III Rectal Cancer.
Clin Colorectal Cancer
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38851990
3.
Trifluridine-tipiracil plus bevacizumab versus capecitabine plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer ineligible for intensive therapy (SOLSTICE): a randomised, open-label phase 3 study.
Lancet Gastroenterol Hepatol
; 8(2): 133-144, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36470291